Cargando…
Utility of 5-ALA for resection of CNS tumours other than high-grade gliomas: a protocol for a systematic review
INTRODUCTION: 5-aminolevulinic acid (5-ALA) is a proagent developed for fluorescent-guided surgery for high-grade glioma patients associated with a significant increase in resection conferring survival. 5-ALA was shown to penetrate the blood–brain barrier accumulating in malignant glioma cells with...
Autores principales: | Solomou, Georgios, Gharooni, Aref-Ali, Patel, Waqqas, Gillespie, Conor S, Gough, Melissa, Venkatesh, Ashwin, Poon, Michael T C, Wykes, Victoria, Price, Stephen John, Jenkinson, Michael D, Watts, Colin, Plaha, Puneet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315896/ https://www.ncbi.nlm.nih.gov/pubmed/35868820 http://dx.doi.org/10.1136/bmjopen-2021-056059 |
Ejemplares similares
-
Advances in Research of Adult Gliomas
por: Finch, Alina, et al.
Publicado: (2021) -
5-ALA fluorescence in indeterminate grade gliomas
por: Müther, Michael, et al.
Publicado: (2022) -
The role of [(18)F]fluorodopa positron emission tomography in grading of gliomas
por: Roach, Joy R., et al.
Publicado: (2022) -
Impact of COVID-19 pandemic on surgical neuro-oncology multi-disciplinary team decision making: a national survey (COVID-CNSMDT Study)
por: Price, Stephen John, et al.
Publicado: (2020) -
The Neurology and Neurosurgery Interest Group (NANSIG)—ten years of cultivating interest in clinical neurosciences
por: Park, Jay J., et al.
Publicado: (2022)